HempFusion exceeds new store targets for the year with products now available in 18,000 retail locations
DENVER, Nov. 4, 2021 – (BUSINESS WIRE) – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) (“HempFusion” or the “Company”), a leading healthcare and wellness company, which offers high-quality probiotic supplements and products containing CBD, is pleased to announce that another top 15 US supermarket chain has launched HempFusion products in the southeastern United States. HempFusion’s OTC (Over-the-Counter) Pain Relief Cream will be available in approximately 400 stores, and HempFusion’s ingestible and topical CBD products will now be available in 75 targeted stores.
“This new top 15 grocer in the US builds on our recent announcements to bring our ingestible and topical CBD products to a major Arizona grocery chain, as well as the four SKUs our Sagely Naturals division in one of the top 10 US publicly traded Food, Drug & Mass (FDM) retailers, “said Jason Mitchell, ND, co-founder and chief executive officer of HempFusion – and wellness brands. HempFusion and its family of brands have increased the number of doors for our products from around 15,000 locations to over 18,000 locations since the beginning of 2021. Establishing the company as the leading health and wellness brand through our multi-channel strategy, including of the FDM channel. Our most recent predictions for the market were that we would have 2,000 more by the end of 2021 Locations will open, and we have already exceeded this goal with more than 3,000 new locations to date, and the trend is rising, “said Dr. Mitchell continues.
HempFusion is the first brand from this grocery retailer in the southeastern USA to be available on the shelf in the analgesics segment with an OTC pain relief cream with 1.75% menthol and CBD from hemp with a broad spectrum. The skin care cream will be available in around 400 stores.
The story goes on
Twelve additional SKUs from HempFusions Ingestibles, including USDA-certified organic tinctures, gummies, sleep and stress support capsules, and a variety of topicals including eczema relief cream and pain relief balm, are on CBD in nearly 100 stores. Devices.
As one of the few CBD companies fully prepared today to meet or exceed expected FDA guidelines, HempFusion Wellness Inc. is a leading health and wellness company whose family of premium consumer brands HempFusion ™, Sagely Naturals ™ , Apothecanna ™ and Probulin includes Probiotics ™, one of the fastest growing probiotic companies in the United States, according to data reported by SPINs.
The HempFusion family of brands leverages the power of whole-food nutrition and includes 112 SKUs, including USDA organic certified tinctures, proprietary FDA drug-listed over-the-counter (OTC) topicals, probiotic dietary supplements and skin care products, a Doctor / Practitioner Line, a white label department and more. With a strong focus on research and development, HempFusion Wellness has 43 products in development.
HempFusion Wellness products are available in more than 18,000 U.S. retail locations in all 50 states and are also available in China, Mexico, Ireland, the United Kingdom, the United Arab Emirates, South Korea, and Canada, and can be found online through each brand’s website, The Probulin Store. , can be bought on Amazon.com, Alibaba’s Tmall.com, the world’s largest cross-border online marketplace, and a variety of other e-commerce sites.
More information is available at www.hempfusion.com. Follow HempFusion on Twitter, Facebook and Instagram.
This press release contains forward-looking statements and forward-looking information within the meaning of Canadian securities laws (collectively, “forward-looking statements”) that relate to HempFusion’s current expectations and beliefs about future events. Any statements that express or discuss expectations, beliefs, plans, goals, assumptions or future events or performance (often, but not always, through the use of words or expressions such as “will likely result,” “are expected to.” “,” expects “,” continues “,” is expected “,” anticipated “,” believes “,” estimated “,” intends “,” plans “,” forecast “,” forecast “,” strategy “,” objective. ” “and” Outlook “) are not historical facts and may be forward-looking statements and contain estimates, assumptions and uncertainties that could cause actual results or results to differ materially from those expressed in such forward-looking statements. That these expectations will prove to be correct and one should not place undue reliance on such forward-looking statements in this press release en apply only as of the date of this press release. In particular, and without limitation, this press release contains forward-looking statements relating to the company’s expanding retail presence and the company’s other plans, focuses, and goals.
Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the control of HempFusion, which could cause actual results and events to differ materially from those disclosed or implied in these forward-looking statements Statement. These risks and uncertainties include, but are not limited to, the effects and progression of the COVID-19 pandemic and other factors set out in the “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” on the company’s annual information form dated March 31, 2021 and below Company profile available on SEDAR at www.sedar.com. HempFusion assumes no obligation to update or revise any forward-looking statements as a result of new information, future events or for any other reason, except as required by law. From time to time new factors will emerge and it will not be possible for HempFusion to predict all of them or to assess the impact of each of these factors or the extent to which any one or combination of factors may cause the results to differ materially the differences contained in every forward-looking statement. All forward-looking statements in this press release are expressly restricted in their entirety by this cautionary statement.
Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005220/en/
Jason Mitchell, ND
Managing Director and Director